Anti-CEACAM6 antibody [EPR23956-80]
- 20ul selling size
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(4 Publications)
Rabbit Recombinant Monoclonal CEAM6 antibody. Suitable for ICC/IF, IP, Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 4 publications.
View Alternative Names
CD66c, NCA, CEACAM6, Cell adhesion molecule CEACAM6, Carcinoembryonic antigen-related cell adhesion molecule 6, Non-specific crossreacting antigen, Normal cross-reacting antigen, CEA cell adhesion molecule 6
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CEACAM6 antibody [EPR23956-80] (AB275022)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized BxPC-3 BxPC-3 (human pancreas adenocarcinoma cell) cells labelling CEACAM6 with ab275022 at 1/500 (1.048 ug/ml) dilution, followed by ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) antibody at 1/1000 dilution (Green). Confocal image showing membranous and cytoplamic staining in BxPC-3 cell line. Low expression control : LNCaP : PMID : 16204051. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The counterstain was DAPI (Blue).
Secondary antibody only control : Secondary antibody is ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1/1000 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM6 antibody [EPR23956-80] (AB275022)
Immunohistochemical analysis of paraffin-embedded human spleen tissue labeling CEACAM6 with ab275022 at 1/2000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on human spleen. The section was incubated with ab275022 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM6 antibody [EPR23956-80] (AB275022)
Immunohistochemical analysis of paraffin-embedded human colon cancer tissue labeling CEACAM6 with ab275022 at 1/2000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on human colon cancer (PMID : 27284373). The section was incubated with ab275022 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- Flow Cyt
Unknown
Flow Cytometry - Anti-CEACAM6 antibody [EPR23956-80] (AB275022)
Flow cytometric analysis of LNCaP (human prostate carcinoma epithelial cell, Left) / BxPC-3 (human pancreas adenocarcinoma epithelial cell, Right) cells labelling CEACAM6 with ab275022 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (ab172730) isotype control (Black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue).
Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.
Negative control : LNCaP.
Gated on viable cells.
- IP
Unknown
Immunoprecipitation - Anti-CEACAM6 antibody [EPR23956-80] (AB275022)
CEACAM6 was immunoprecipitated from 0.35 mg BxPC-3 (human pancreas adenocarcinoma epithelial cell) whole cell lysate with ab275022 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab275022 at 1/2000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : BxPC-3 (human pancreas adenocarcinoma epithelial cell) whole cell lysate 10 ug
Lane 2 : ab275022 IP in BxPC-3 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab275022 in BxPC-3 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.
All lanes:
Immunoprecipitation - Anti-CEACAM6 antibody [EPR23956-80] (ab275022)
Predicted band size: 37 kDa
Observed band size: 40-100 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-CEACAM6 antibody [EPR23956-80] (AB275022)
CEACAM6 was immunoprecipitated from 0.35 mg A549 (human lung carcinoma epithelial cell) whole cell lysate with ab275022 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab275022 at 1/2000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : A549 (human lung carcinoma epithelial cell) whole cell lysate 10 ug
Lane 2 : ab275022 IP in A549 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab275022 in A549 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.
All lanes:
Immunoprecipitation - Anti-CEACAM6 antibody [EPR23956-80] (ab275022)
Predicted band size: 37 kDa
Observed band size: 40-100 kDa
false
- WB
Unknown
Western blot - Anti-CEACAM6 antibody [EPR23956-80] (AB275022)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure times : Lanes 1-2 : 15 seconds; Lane3 : 3 seconds; Lane 4 : 26 seconds.
The molecular weight observed is consistent with what has been described in the literature (PMID : 19244123, 28892050, 16204051).
Low expression control : LNCaP (PMID : 16204051).
All lanes:
Western blot - Anti-CEACAM6 antibody [EPR23956-80] (ab275022) at 1/1000 dilution
Lane 1:
A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
LNCaP (human prostate carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
BxPC-3 (human pancreas adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
LoVo (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 37 kDa
Observed band size: 40-100 kDa
false
- WB
Unknown
Western blot - Anti-CEACAM6 antibody [EPR23956-80] (AB275022)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 26 seconds.
The molecular weight observed is consistent with what has been described in the literature (PMID : 19244123, 28892050, 16204051).
All lanes:
Western blot - Anti-CEACAM6 antibody [EPR23956-80] (ab275022) at 1/1000 dilution
All lanes:
Human lung tissue lysate at 20 µg
Secondary
All lanes:
VeriBlot for IP secondary antibody(HRP)(<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 37 kDa
Observed band size: 40-100 kDa
false
- WB
Unknown
Western blot - Anti-CEACAM6 antibody [EPR23956-80] (AB275022)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 15 seconds.
The other family members have lower homology than the tested proteins.
All lanes:
Western blot - Anti-CEACAM6 antibody [EPR23956-80] (ab275022) at 1/1000 dilution
Lane 1:
His-tagged human CEACAM6 recombinant protein, 20ng
Lane 2:
His-tagged human CEACAM1 recombinant protein (aa35-428), 20ng
Lane 3:
His-tagged human CEACAM5 recombinant protein (aa35-685), 20ng
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 37 kDa
false
Related conjugates and formulations (4)
-
Anti-CEACAM6 antibody [EPR23956-80] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CEACAM6 antibody [EPR23956-80]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CEACAM6 antibody [EPR23956-80]
-
578 PE
PE Anti-CEACAM6 antibody [EPR23956-80]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CEACAM6 acts in cell signaling and adhesion processes. It often forms complexes with other members of the CEACAM family such as CEACAM5. This protein is involved in the regulation of cell-cell adhesion which impacts cell migration and organization. It also influences immune reactions by modulating the interactions between pathogens and host cells.
Pathways
CEACAM6 integrates into pathways associated with cell adhesion and immune regulation. It engages in the PI3K-Akt signaling pathway tightly interacting with proteins such as CEACAM1 and CEACAM5. Through these interactions CEACAM6 plays an essential role in cell survival proliferation and immune responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
NPJ precision oncology 9:115 PubMed40263546
2025
Applications
Unspecified application
Species
Unspecified reactive species
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 28:422-441 PubMed39918687
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 4:101277 PubMed37944531
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:643669 PubMed34221964
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com